Alternative Investment Instruments
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -3087.9% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 50.1 | n/a |
| Pr/Book | 0.9 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 346.2% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-20 | n/a | (0.09) | (0.51)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-21 | n/a | (0.06) | 0.00p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-22 | n/a | (0.93) | (2.06)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-23 | 0.01 | (1.58) | (1.59)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-24 | 0.06 | (1.80) | (1.62)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Result of General Meeting | 17-Dec-2025 | 11:08 | RNS |
| 3D Bio-Tissues Signs Supply Agreement with SeaWith | 16-Dec-2025 | 07:00 | RNS |
| Changes to timetable for proposed Equity Fundraise | 15-Dec-2025 | 07:00 | RNS |
No recent information was found.
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 2.35p |
| Change Today | 0.15p |
| % Change | 6.82 % |
| 52 Week High | 2.50 |
| 52 Week Low | 2.00 |
| Volume | 1,840,343 |
| Shares Issued | 123.65m |
| Market Cap | £2.91m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:15 | 1 @ 2.50p |
| 16:13 | 100,000 @ 2.33p |
| 16:12 | 250,000 @ 2.33p |
| 16:12 | 150,000 @ 2.34p |
| 13:23 | 5 @ 2.20p |
| CEO | Che John Connon |
| CFO | Graham Duncan |
You are here: research